Application list for self inspection and registration of 7 clinical trial data

The official website of the State Drug Administration announced that it had decided to verify the clinical trial data of seven newly received drug registration applications that had completed the clinical trial declaration and production. According to the announcement, before the inspection organized by the State Drug Administration, if the drug registration applicant finds the authenticity of the drug clinical trial data through self inspection, he / she shall withdraw the registration application actively, and the State Drug Administration shall publish the list of drug registration applicants, and shall not investigate their responsibilities.The food and drug audit and inspection center of the State Drug Administration will publicize the on-site inspection plan on its website, and notify the drug registration applicant and its local provincial drug regulatory department. After 10 working days of publicity, the center will notify the on-site inspection date and no longer accept the withdrawal application of the drug registration applicant. For the applicant, the person in charge and manager of drug clinical trial, and the person in charge of contract research organization who found data fraud in the on-site verification of drug clinical trial data, SDA will deal with it seriously according to law. Application list for self inspection and registration of clinical trial data of 7 drugs
2026-10-16
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
India Proposes New GMP Rules for Clinical Trial and API Manufacturing
-
India's PV Community Comes Together at the 6th Edition Drug Safety Symposium 2026 – India Chapter to Shape the Future of Patient Safety
-
6th Drug Safety Symposium 2026 to Focus on “Beyond Algorithms & Assumptions, What Actually Matters in Pharmacovigilance”
-
Roche Acquires Carmot for $3.1 Billion to Enter Obesity Drug Market
-
Two departments issued a document to guidethe strengthening of drug cases investigation and handling
-
National Health Care Commission: 50% of thecountry's public hospitals above the second level have carried out appointmentdiagnosis and treatment services
-
India starts testing a pharmaceuticalcompany's exports of cough syrup
-
Inmanar Announces Several BreakthroughSequencing Innovations
-
China's medical supplies supply securitycapabilities continue to enhance
-
244 medical device concept stocks roseindustry insiders said the process of domestic replacement is expected toaccelerate
Recommend Reading
-
Japanese Plastics Market Accelerates its Shifts to Recycled Materials and Bioplastics
-
“The 40-Year Ethylene Giant Collapses”: ExxonMobil’s Premature Shutdown Is Not Just Scotland’s Tragedy—It’s the Twilight Elegy of European Industrial Civilization
-
“Amputation or Strategic Retreat?”: Shell’s Six-Year Chemical Losses and the Quiet Unwinding of an Empire
-
Solvay's "Slimming Action": Soda Ash Production Capacity in Spain Slashed by 180,000 Tons, 77 Jobs to Go
-
Titanium Dioxide Prices Are Up Again! This Round of Increases Has One Real Driver: Sulfuric Acid
-
Premium Global Chemical Sourcing Requests (19 - 22 Mar, 2026)
-
Business Society October 15, 2026 Adipic Acid Trend Analysis: Volatility
-
Business Society October 15, 2026 Acrylic Acid Trend Analysis: Strong Consolidation
-
Cost Pushes Combined with Moving Average Golden Cross: Acrylic Acid Market Strongly Holds Prices and Rises
-
Business Society October 14, 2026 BDO Trend Analysis: Volatile with a Bearish Bias